WO2007054969A3 - Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride - Google Patents
Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride Download PDFInfo
- Publication number
- WO2007054969A3 WO2007054969A3 PCT/IN2006/000376 IN2006000376W WO2007054969A3 WO 2007054969 A3 WO2007054969 A3 WO 2007054969A3 IN 2006000376 W IN2006000376 W IN 2006000376W WO 2007054969 A3 WO2007054969 A3 WO 2007054969A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lercanidipine
- preparation
- amorphous form
- hydrochloride
- lercanidipine hydrochloride
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to new, improved and industrially viable process for the preparation of Lercanidipine or its pharmaceutically acceptable salts using novel derivatives of 2,N-dimethyl-N-(3,3-diphenylpropyl)-l -amino compounds and novel polymorphs of Lercanidipine hydrochloride, its process of preparation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06842760A EP1963254A2 (en) | 2005-09-21 | 2006-09-19 | Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1164/MUM/2005 | 2005-09-21 | ||
IN1164MU2005 | 2005-09-21 | ||
IN1593/MUM/2005 | 2005-12-19 | ||
IN1593MU2005 | 2005-12-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007054969A2 WO2007054969A2 (en) | 2007-05-18 |
WO2007054969A3 true WO2007054969A3 (en) | 2007-11-01 |
Family
ID=38023682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2006/000376 WO2007054969A2 (en) | 2005-09-21 | 2006-09-19 | Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1963254A2 (en) |
WO (1) | WO2007054969A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR052918A1 (en) | 2005-02-25 | 2007-04-11 | Recordati Ireland Ltd | LERCANIDIPINE AMORFO CHLORHYDRATE |
DK2164349T3 (en) | 2006-08-04 | 2014-12-15 | Shs Int Ltd | protein-FORMULA |
KR100928995B1 (en) * | 2007-10-31 | 2009-11-26 | (주)에이에스텍 | Amorphous anhydrous lercanidipine and its improved preparation |
CN102686594A (en) | 2009-12-16 | 2012-09-19 | 熙德隆研究基金会 | Polymorphs of darunavir |
EP2571355B1 (en) | 2010-05-20 | 2016-09-07 | Hetero Research Foundation | Crystalline hydrochloride salt of darunavir |
EP2444394A1 (en) * | 2010-10-21 | 2012-04-25 | Alembic Pharmaceuticals Limited | Process for the preparation of amorphous form of lercanidipine HCI |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0153016A2 (en) * | 1984-02-14 | 1985-08-28 | RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY | Asymmetrical diesters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid |
-
2006
- 2006-09-19 EP EP06842760A patent/EP1963254A2/en not_active Withdrawn
- 2006-09-19 WO PCT/IN2006/000376 patent/WO2007054969A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0153016A2 (en) * | 1984-02-14 | 1985-08-28 | RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY | Asymmetrical diesters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid |
Non-Patent Citations (1)
Title |
---|
LEONARDI A ET AL: "Asymmetric N-(3,3-diphenylpropyl)aminoalkyl esters of 4-aryl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acids with antihypertensive activity", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, vol. 33, no. 5, June 1998 (1998-06-01), pages 399 - 420, XP004127371, ISSN: 0223-5234 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007054969A2 (en) | 2007-05-18 |
EP1963254A2 (en) | 2008-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010033444A8 (en) | Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent hcv inhibitor | |
WO2006067103A3 (en) | Process for the preparation of a 2-pyridylethylcarboxamide derivative | |
WO2009139817A3 (en) | Crystalline pharmaceutical and methods of preparation and use thereof | |
WO2007058583A3 (en) | Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies | |
WO2010001257A3 (en) | Novel solid state forms of laquinimod and its sodium salt | |
TW200714586A (en) | Crystalline forms of a biphenyl compound | |
WO2006081515A3 (en) | Duloxetine hydrochloride polymorphs | |
WO2007056219A3 (en) | [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto | |
WO2007103456A3 (en) | Piperazine and piperidine biaryl derivatives | |
WO2008001195A3 (en) | Novel processes for the preparation of dpp iv inhibitors | |
WO2009141718A3 (en) | Process for the preparation of prostaglandin analogues and intermediates thereof | |
WO2010070677A3 (en) | A process for the preparation of prasugrel and its pharmaceutically acceptable salts thereof | |
WO2007054969A3 (en) | Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride | |
EA200701687A1 (en) | Amorphous hydrochloride lorkanidipine | |
WO2007119120A3 (en) | Crystalline polymorphic forms of olopatadine hydrochloride and processes for their preparation | |
RS11304A (en) | Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation | |
WO2007131907A3 (en) | 1h-indol-5-yl-piperazin-1-yl-methanone derivatives | |
EP3020704A3 (en) | Crystalline polymorphs of clevidipine butyrate | |
WO2005123670A3 (en) | Crystalline form of a substituted pyrrolidine compound | |
WO2004111008A3 (en) | Use of a compound of formula i for making a pharmaceutical composition | |
WO2008074693A3 (en) | Process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone | |
WO2009125975A3 (en) | Combination of mitiglinide and metformin and process for preparing same | |
WO2007144699A3 (en) | Process for the preparation of alfuzosin | |
WO2007009143A3 (en) | Method for producing nebivolol | |
WO2008059513A3 (en) | Compounds suitable as modulators of hdl |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006842760 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2006842760 Country of ref document: EP |